- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 39/12 - Viral antigens
Patent holdings for IPC class A61K 39/12
Total number of patents in this class: 9238
10-year publication summary
429
|
590
|
674
|
708
|
840
|
766
|
856
|
842
|
686
|
194
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Glaxosmithkline Biologicals S.A. | 1701 |
245 |
The United States of America, as represented by the Secretary, Department of Health and Human Services | 2737 |
174 |
Janssen Vaccines & Prevention B.V. | 337 |
142 |
The Trustees of the University of Pennsylvania | 4122 |
135 |
Intervet Inc. | 848 |
116 |
Intervet International B.V. | 1235 |
116 |
Takeda Vaccines, Inc. | 199 |
98 |
Zoetis Services LLC | 1537 |
98 |
Boehringer Ingelheim Animal Health USA Inc. | 507 |
94 |
The Regents of the University of California | 18943 |
80 |
Boehringer Ingelheim Vetmedica GmbH | 1290 |
78 |
Immatics Biotechnologies GmbH | 1144 |
78 |
Modernatx, Inc. | 1181 |
76 |
Inovio Pharmaceuticals, Inc. | 308 |
75 |
Institut Pasteur | 798 |
73 |
Duke University | 2872 |
68 |
Bavarian Nordic A/S | 260 |
61 |
Curevac SE | 235 |
60 |
Massachusetts Institute of Technology | 9795 |
55 |
The Wistar Institute of Anatomy and Biology | 387 |
55 |
Other owners | 7261 |